Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study (Q51055764)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 November 2016

Language	Label	Description	Also known as
English	Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study	scientific article published on 21 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Thomas Fremming Dejgaard

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Henrik U Andersen

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Jens Juul Holst

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Bolette Hartmann

object named as

Bolette Hartmann

5

0 references

Birger Thorsteinsson

6

object named as

Birger Thorsteinsson

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Christian Seerup Frandsen

1

object named as

Christian S Frandsen

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

publication date

21 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

19

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

773-782

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Standards of medical care in diabetes--2014

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Effect of plasma amino acid replacement on glucagon and substrate responses to insulin-induced hypoglycemia in humans

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Liraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Vagal, cholinergic regulation of pancreatic polypeptide secretion

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Relationships between gastric emptying, postprandial glycemia, and incretin hormones

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

1 reference

https://api.crossref.org/works/10.1111/DOM.12830

21 January 2018

Identifiers

10.1111/DOM.12830

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/27868372

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51055764&oldid=2266606579"